221 related articles for article (PubMed ID: 17850927)
1. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
Sjölander A; Minthon L; Bogdanovic N; Wallin A; Zetterberg H; Blennow K
Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.
Tedde A; Putignano AL; Nacmias B; Bagnoli S; Cellini E; Sorbi S
Neurosci Lett; 2008 Dec; 446(2-3):139-42. PubMed ID: 18834925
[TBL] [Abstract][Full Text] [Related]
4. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
[TBL] [Abstract][Full Text] [Related]
5. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
6. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
Helisalmi S; Tarvainen T; Vepsäläinen S; Koivisto AM; Hiltunen M; Soininen H
Neurosci Lett; 2008 Aug; 441(2):233-6. PubMed ID: 18573313
[TBL] [Abstract][Full Text] [Related]
7. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease.
Maes OC; Schipper HM; Chong G; Chertkow HM; Wang E
Neurobiol Aging; 2010 Jan; 31(1):34-45. PubMed ID: 18423940
[TBL] [Abstract][Full Text] [Related]
8. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
Culpan D; Cram D; Chalmers K; Cornish A; Palmer L; Palmer J; Hughes A; Passmore P; Craig D; Wilcock GK; Kehoe PG; Love S
Neurobiol Aging; 2009 Jul; 30(7):1052-60. PubMed ID: 18069092
[TBL] [Abstract][Full Text] [Related]
9. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
Rodríguez-Rodríguez E; Sánchez-Juan P; Mateo I; Llorca J; Infante J; García-Gorostiaga I; Berciano J; Combarros O
Acta Neurol Scand; 2007 Dec; 116(6):409-12. PubMed ID: 17986101
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
Arosio B; Trabattoni D; Galimberti L; Bucciarelli P; Fasano F; Calabresi C; Cazzullo CL; Vergani C; Annoni G; Clerici M
Neurobiol Aging; 2004 Sep; 25(8):1009-15. PubMed ID: 15212825
[TBL] [Abstract][Full Text] [Related]
11. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer's disease.
Coppedè F; Mancuso M; Lo Gerfo A; Manca ML; Petrozzi L; Migliore L; Siciliano G; Murri L
Neurosci Lett; 2007 Mar; 414(3):282-5. PubMed ID: 17240059
[TBL] [Abstract][Full Text] [Related]
12. Gene variations in GSTM3 are a risk factor for Alzheimer's disease.
Hong GS; Heun R; Jessen F; Popp J; Hentschel F; Kelemen P; Schulz A; Maier W; Kölsch H
Neurobiol Aging; 2009 May; 30(5):691-6. PubMed ID: 17904251
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
Segat L; Milanese M; Arosio B; Vergani C; Crovella S
Neurobiol Aging; 2010 Jan; 31(1):162-4. PubMed ID: 18433937
[TBL] [Abstract][Full Text] [Related]
14. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C
Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205
[TBL] [Abstract][Full Text] [Related]
15. Three SNPs in the GSTO1, GSTO2 and PRSS11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease.
Ozturk A; Desai PP; Minster RL; Dekosky ST; Kamboh MI
Neurobiol Aging; 2005; 26(8):1161-5. PubMed ID: 15917099
[TBL] [Abstract][Full Text] [Related]
16. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
Lamsa R; Helisalmi S; Herukka SK; Tapiola T; Pirttila T; Vepsalainen S; Hiltunen M; Soininen H
Dement Geriatr Cogn Disord; 2007; 24(2):146-50. PubMed ID: 17622762
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
Blomqvist ME; Andreasen N; Bogdanovic N; Blennow K; Brookes AJ; Prince JA
Neurosci Lett; 2004 Apr; 358(3):220-2. PubMed ID: 15039120
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
[TBL] [Abstract][Full Text] [Related]
19. Case-control study of vascular endothelial growth factor (VEGF) genetic variability in Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Sánchez-Quintana C; Sánchez-Juan P; Berciano J; Combarros O
Neurosci Lett; 2006 Jun; 401(1-2):171-3. PubMed ID: 16569480
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease.
Wang B; Zhou S; Yang Z; Xie YC; Wang J; Zhang P; Lv Z; Zheng C; Ma X
J Neurol Sci; 2008 Jul; 270(1-2):148-51. PubMed ID: 18396294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
